Cardiovascular Health And Risk Modification in Family Health Teams

Phase 3

Completed

• Conditions: Diabetes; Hypertension; Hyperlipidemia; Cardiovascular Risk Factors
• Interventions: Behavioral: Active risk factor surveillance

• Registration Number: NCT00787306
• Lead Sponsor: University of Toronto

Brief Summary

Cardiovascular diseases remain the main cause of mortality in Canada. While effective interventions are available for reducing the risk of cardiovascular disease,there continue to be gaps between the potential reduction in risk that could be achieved by effectively managing these risk factors and levels of risk factor control currently in clinical practice. This study will evaluate the ability of a different model of risk factor care using other health providers assisting family doctors, along with information aids for patients and health professionals,to achieve better levels of cardiovascular risk factor control in adults.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-10
• Study First Submitted: 2008-11-06
• Study First Submitted QC: 2008-11-06
• Study First Posted: 2008-11-07
• Primary Completion: 2009-06
• Study Completion: 2009-06
• Status Verified: 2018-03
• Last Update Submitted: 2018-03-31
• Last Update Posted: 2018-04-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 229

Inclusion Criteria

• adults 50 to 80 years of age
• having attending a family medicine clinic for more than one year

Read More

Exclusion Criteria

• not able to participate for one year
• not able to read English
• requires house calls
• nursing home resident
• cognitive impairment
• current chest pain or symptoms of active coronary heart disease

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Multi-faceted Cardiovascular Decision Support	Active risk factor surveillance	Risk factor active surveillance, multi-disciplinary disease management and decision aid intervention
Control Usual Care	Active risk factor surveillance	Usual care in a wait-list control arm that receives the experimental intervention after 6 months.

Primary Outcome Measures

Name	Time	Method
mean systolic blood pressure	6 months

Secondary Outcome Measures

Name	Time	Method
Proportion of adults with 3 cardiovascular risk factors under optimal control	6 months

Trial Locations

Locations (1)

Granovsky Gluskin Family Medicine Cwntre; 🇨🇦 Toronto, Ontario, Canada